NCT06805773 Evaluating the Use of Educational Videos in Newly Diagnosed Patients in a Medical Oncology Sarcoma Clinic
| NCT ID | NCT06805773 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mount Sinai Hospital, Canada |
| Condition | Sarcoma |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-05-05 |
| Primary Completion | 2026-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-05-05 with a primary completion date of 2026-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate how sarcoma-specific educational videos improve patients' knowledge of their disease and treatment options before their first clinic appointment. Participants will watch four educational videos before their first appointment with a medical oncologist. Participants will be asked to complete surveys to assess their understanding of sarcoma and its treatment options before and after their first medical oncology clinic appointment.
Eligibility Criteria
Inclusion Criteria: 1. Signed written and voluntary informed consent. 2. Have histologically documented advanced metastatic sarcoma, or is a caregiver of a patient with histologically documented advanced metastatic sarcoma. 3. Age ≥ 18 years. 4. Have not received any previous systemic treatment for sarcoma, or is a caregiver of a sarcoma patient who has not received any previous systemic treatment for sarcoma. 5. Willing/able to complete questionnaires. 6. Able to read and write in English. Exclusion Criteria: 1. Inability to provide informed consent. 2. Previously seen by a medical oncologist for their sarcoma.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06805773 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Sarcoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06805773 currently recruiting?
Yes, NCT06805773 is actively recruiting participants. Contact the research team at Oncology.Research@sinaihealth.ca for enrollment information.
Where is the NCT06805773 trial being conducted?
This trial is being conducted at Toronto, Canada.
Who is sponsoring the NCT06805773 clinical trial?
NCT06805773 is sponsored by Mount Sinai Hospital, Canada. The trial plans to enroll 100 participants.